SUS.ST
Surgical Science Sweden AB (publ)
StockholmSEKEQUITY
Healthcare
DELAYED
Last price
49.20
▼ 0.10 (0.20%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
50.20
Prev close
49.30
Day high
50.20
Day low
47.80
Volume
315.20K
Market cap
$2.51B
P/E (TTM)
27.03
52W range
23.70 – 109.30
Day trading desk
Gap from prior close
+1.83%
Prior close 49.30
VWAP
48.64
+1.14% from price
Relative volume
6.77×
Unusually busy
Session range
5.02%
47.80 – 50.20
Position in range
58%
Mid range
ATR (14D)
2.44
4.95% of price
Prior day high
51.50
PDH
Prior day low
48.60
PDL
Bid / ask spread
—
Quote not published
Session volume
1.15M
Avg 169.57K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+28.80%
+30.2%
1M
+62.91%
+59.2%
3M
+31.55%
+28.5%
6M
+69.07%
+58.0%
YTD
+51.38%
+39.1%
1Y
-50.85%
-70.8%
3Y
-77.26%
-151.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SUS.ST open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
13.48M
Total on file
Fundamentals
Market cap$2.51B
Enterprise value$1.85B
Revenue (TTM)$1.02B
Gross profit$679.94M
EBITDA$138.99M
Net income$93.14M
EPS (TTM)$1.82
Free cash flow$-39.11M
Total cash$658.39M
Total debt$2.86M
Book value / share$86.53
Shares outstanding51.03M
Float36.94M
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E27.03
Forward P/E10.10
PEG ratio—
Price / sales—
Price / book0.57
EV / revenue1.81
EV / EBITDA13.29
Gross margin66.50%
Operating margin12.84%
Profit margin9.11%
Return on equity2.10%
Return on assets1.43%
Debt / equity0.06
Current ratio4.24
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $992.34M | $884.09M | $882.85M | $802.54M | +12.2% |
| Operating revenue | $992.34M | $884.09M | $882.85M | $802.54M | +12.2% |
| Cost of revenue | $334.67M | $286.19M | $269.97M | $271.02M | +16.9% |
| Gross profit | $657.68M | $597.90M | $612.88M | $531.52M | +10.0% |
| Research & development | $222.11M | $196.11M | $181.57M | $172.79M | +13.3% |
| Selling, general & admin | $276.49M | $213.57M | $203.61M | $201.88M | +29.5% |
| Total operating expense | $588.79M | $453.58M | $423.73M | $368.98M | +29.8% |
| Operating income | $68.88M | $144.32M | $189.15M | $162.54M | -52.3% |
| Net interest income | $11.54M | $18.28M | $64.07M | $45.64M | -36.9% |
| Pre-tax income | $100.14M | $158.09M | $268.26M | $208.17M | -36.7% |
| Tax provision | $33.32M | $26.45M | $34.29M | $20.20M | +26.0% |
| Net income | $66.82M | $131.65M | $233.97M | $187.97M | -49.2% |
| Net income to common | $66.82M | $131.65M | $233.97M | $187.97M | -49.2% |
| Basic EPS | 1.31 | 2.58 | 4.59 | 3.70 | -49.2% |
| Diluted EPS | 1.31 | 2.58 | 4.59 | 3.69 | -49.2% |
| EBIT | $106.42M | $163.77M | $268.92M | $209.48M | -35.0% |
| EBITDA | $189.79M | $224.29M | $324.53M | $261.06M | -15.4% |
| Basic shares | 51.03M | 51.03M | 50.93M | 50.80M | 0.0% |
| Diluted shares | 51.03M | 51.03M | 50.94M | 50.91M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $616.42M | $968.15M | $634.37M | $433.73M | — | -36.3% |
| Cash & short-term investments | $616.42M | $968.15M | $634.37M | $433.73M | — | -36.3% |
| Accounts receivable | $136.98M | $136.70M | $110.60M | $176.31M | — | +0.2% |
| Inventory | $205.97M | $179.58M | $154.45M | $134.88M | — | +14.7% |
| Total current assets | $1.18B | $1.43B | $991.19M | $826.37M | — | -16.9% |
| Property, plant & equipment | $106.35M | $101.53M | $76.62M | $51.36M | — | +4.7% |
| Goodwill & intangibles | $3.38B | $3.93B | $3.62B | $3.75B | — | -14.0% |
| Total assets | $4.69B | $5.48B | $4.70B | $4.65B | — | -14.4% |
| Total current liabilities | $292.76M | $512.72M | $234.94M | $305.91M | — | -42.9% |
| Current debt | $1.63M | — | — | — | — | — |
| Long-term debt | — | $235.41M | — | — | $29.42M | — |
| Total debt | $56.40M | $56.94M | $40.02M | $14.68M | — | -1.0% |
| Total liabilities | $418.31M | $651.03M | $357.46M | $413.11M | — | -35.7% |
| Retained earnings | $706.23M | $639.41M | $507.76M | $273.79M | — | +10.4% |
| Shareholder equity | $4.27B | $4.83B | $4.35B | $4.24B | — | -11.5% |
| Working capital | $891.92M | $913.28M | $756.25M | $520.46M | — | -2.3% |
| Net tangible assets | $894.92M | $900.89M | $729.96M | $491.14M | — | -0.7% |
| Shares issued | 51.03M | 51.03M | 51.03M | 50.80M | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $68.88M | $144.32M | $189.15M | $162.54M | -52.3% |
| Depreciation & amortisation | $83.37M | $60.51M | $55.61M | $51.59M | +37.8% |
| Change in working capital | -$61.70M | -$65.89M | -$5.65M | -$65.61M | +6.4% |
| Operating cash flow | $79.80M | $137.22M | $238.29M | $129.49M | -41.9% |
| Capital expenditure | -$49.34M | -$47.53M | -$44.13M | -$34.55M | -3.8% |
| Investing cash flow | -$134.25M | -$47.53M | -$44.13M | -$34.55M | -182.5% |
| Financing cash flow | -$259.68M | $227.65M | $15.85M | $17.09M | -214.1% |
| Free cash flow | $30.46M | $89.69M | $194.16M | $94.94M | -66.0% |
| End cash position | $616.42M | $968.15M | $634.37M | $433.73M | -36.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $235.48M | $268.85M | $263.64M | $209.16M | $250.69M | -12.4% |
| Operating revenue | $235.48M | $268.85M | $263.64M | $209.16M | $250.69M | -12.4% |
| Cost of revenue | $80.51M | $90.60M | $93.21M | $72.76M | $78.09M | -11.1% |
| Gross profit | $154.97M | $178.25M | $170.43M | $136.39M | $172.60M | -13.1% |
| Research & development | $57.97M | $59.75M | $55.03M | $52.12M | $55.21M | -3.0% |
| Selling, general & admin | $67.38M | $71.50M | $76.95M | $81.28M | $96.87M | -5.8% |
| Total operating expense | $132.10M | $138.11M | $143.18M | $158.78M | $148.66M | -4.4% |
| Operating income | $22.87M | $40.14M | $27.25M | -$22.39M | $23.94M | -43.0% |
| Net interest income | -$1.24M | $2.35M | $2.90M | $3.67M | $22.27M | -152.8% |
| Pre-tax income | $21.63M | $42.49M | $30.15M | -$18.72M | $46.21M | -49.1% |
| Tax provision | $3.00M | $9.24M | $9.75M | $1.36M | $12.97M | -67.5% |
| Net income | $18.63M | $33.26M | $20.40M | -$20.08M | $33.24M | -44.0% |
| Net income to common | $18.63M | $33.26M | $20.40M | -$20.08M | $33.24M | -44.0% |
| Basic EPS | 0.37 | 0.65 | 0.40 | -0.39 | 0.65 | -43.1% |
| Diluted EPS | 0.37 | 0.65 | 0.40 | -0.39 | 0.65 | -43.1% |
| EBIT | $22.87M | $40.14M | $27.25M | -$22.39M | $23.94M | -43.0% |
| EBITDA | $22.87M | $40.14M | $27.25M | -$22.39M | $23.94M | -43.0% |
| Basic shares | 51.03M | 51.03M | 51.03M | 51.03M | 51.03M | 0.0% |
| Diluted shares | 51.03M | 51.03M | 51.03M | 51.03M | 51.03M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $667.73M | $616.42M | $597.39M | $610.22M | $612.89M | — | +8.3% |
| Cash & short-term investments | $667.73M | $616.42M | $597.39M | $610.22M | $612.89M | — | +8.3% |
| Accounts receivable | $122.83M | $136.98M | $144.08M | $111.33M | $148.43M | — | -10.3% |
| Inventory | $207.50M | $205.97M | $204.53M | $206.51M | $187.88M | — | +0.7% |
| Total current assets | $1.19B | $1.18B | $1.12B | $1.10B | $1.11B | — | +0.2% |
| Property, plant & equipment | $112.43M | $106.35M | $110.96M | $107.61M | $111.48M | — | +5.7% |
| Goodwill & intangibles | $3.48B | $3.38B | $3.45B | $3.48B | $3.65B | — | +3.1% |
| Total assets | $4.80B | $4.69B | $4.70B | $4.71B | $4.90B | — | +2.4% |
| Total current liabilities | $267.41M | $292.76M | $267.88M | $269.26M | $285.16M | — | -8.7% |
| Current debt | $2.15M | $1.63M | $1.63M | — | $1.64M | — | +32.1% |
| Long-term debt | — | — | — | $1.64M | — | $235.41M | — |
| Total debt | $2.15M | $56.40M | $1.63M | $1.64M | $1.64M | — | -96.2% |
| Total liabilities | $388.73M | $418.31M | $403.58M | $406.24M | $420.50M | — | -7.1% |
| Retained earnings | $724.86M | $706.23M | $672.97M | $652.57M | $672.65M | — | +2.6% |
| Shareholder equity | $4.42B | $4.27B | $4.30B | $4.31B | $4.48B | — | +3.3% |
| Working capital | $919.17M | $891.92M | $852.91M | $830.74M | $824.29M | — | +3.1% |
| Net tangible assets | $933.69M | $894.92M | $850.75M | $823.81M | $823.06M | — | +4.3% |
| Shares issued | 51.03M | 51.03M | 51.03M | 51.03M | 51.03M | — | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $22.87M | $40.14M | $27.19M | -$22.39M | $23.94M | -43.0% |
| Change in working capital | $35.61M | -$3.02M | -$44.55M | $20.02M | -$34.15M | +1,277.3% |
| Operating cash flow | $65.31M | $72.89M | -$4.37M | $16.22M | -$4.96M | -10.4% |
| Capital expenditure | -$17.96M | -$15.12M | -$10.92M | -$12.60M | -$10.70M | -18.7% |
| Investing cash flow | -$17.96M | -$15.12M | -$10.92M | -$12.62M | -$95.58M | -18.7% |
| Financing cash flow | -$3.94M | -$25.66M | $3.98M | -$3.49M | -$234.51M | +84.6% |
| Free cash flow | $47.35M | $57.76M | -$15.29M | $3.63M | -$15.65M | -18.0% |
| End cash position | $667.73M | $616.42M | $597.39M | $610.21M | $612.89M | +8.3% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.46 | 0.48 | +4.2% |
| Mar 2026 | 0.29 | 0.37 | +26.7% |
| Dec 2025 | 0.85 | 0.69 | -18.3% |
| Sep 2025 | 0.72 | 0.40 | -44.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.68 | 3 | $260.65M | -1.1% |
| Next quarter | 0.73 | 3 | $275.82M | +2.6% |
| Current year | 2.23 | 4 | $1.02B | +2.9% |
| Next year | 3.07 | 4 | $1.14B | +11.1% |
Analyst targets & ownership
Mean target$65.40
High target$85.00
Low target$59.00
Implied upside32.93%
Analyst count5
ConsensusSTRONG BUY
Strong buy / Buy1 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders26.50%
Held by institutions44.11%
Institutions holding28
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
41.25
+19.27% from price
SMA 20
37.95
+29.64% from price
SMA 50
33.90
+45.13% from price
SMA 100
33.87
+45.28% from price
SMA 200
36.38
+35.24% from price
EMA 12
41.66
+18.09% from price
EMA 26
38.02
+29.41% from price
EMA 50
35.77
+37.56% from price
RSI (14)
84.3
Overbought
MACD (12,26,9)
3.64
Hist 1.39
ATR (14)
2.44
4.95% of price
Realised vol 30D
69.6%
Annualised
Bollinger upper
47.93
20, 2σ
Bollinger lower
27.97
20, 2σ
50 / 200 cross
Death
33.90 vs 36.38
Trend bias
Above 200
+35.24%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.40
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
69.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-77.8%
Peak to trough
Max drawdown 5Y
-92.8%
Peak to trough
ATR 14
2.44
4.95% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split5:1
Split dateMay 25, 2020
Headlines
The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors
Motley Fool · 4m ago
Nvidia's Q2 earnings to test resurgent AI trade
Yahoo Finance · 7m ago
Prediction: Nvidia Will Be a $6 Trillion Company Before 2026 Is Over and Its Run Kickstarts This Week
Motley Fool · 7m ago
A smooth-talking contractor can cost you thousands — here are key ways to help you hire the right handyman
Moneywise · 12m ago
Where Will SCHD Be in 2035?
Motley Fool · 12m ago
Is Altcoin Season Finally Coming? Market Just Added $215 Billion
BeInCrypto · 17m ago
Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know
Motley Fool · 17m ago
Opera Could Be 28% Below Fair Value Following Q2 Earnings
Simply Wall St. · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.